Analyst Research

Report Title Price
Provider: Stock Traders Daily
Provider: Reuters Investment Profile
Provider: Thomson Reuters Stock Report
Provider: ValuEngine, Inc.

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Retrophin Inc completes acquisition of Manchester Pharmaceuticals LLC

Thursday, 27 Mar 2014 08:00am EDT 

Retrophin Inc:Completion of previously announced acquisition for a total of $62.5 mln.Acquisition brings two products to Retrophin that have been approved by US FDA. 

Related Company News

Company Quote

27 Feb 2015